Vincerx Pharma, Inc. (VINC)

NASDAQ: VINC · IEX Real-Time Price · USD
-0.037 (-5.41%)
At close: Nov 28, 2023, 4:00 PM
+0.052 (8.08%)
After-hours: Nov 28, 2023, 6:13 PM EST

Total Valuation

Vincerx Pharma has a market cap or net worth of $13.69 million. The enterprise value is -$4.55 million.

Market Cap 13.69M
Enterprise Value -4.55M

Important Dates

The last earnings date was Tuesday, November 14, 2023, before market open.

Earnings Date Nov 14, 2023
Ex-Dividend Date n/a

Share Statistics

Vincerx Pharma has 21.38 million shares outstanding. The number of shares has increased by 1.24% in one year.

Shares Outstanding 21.38M
Shares Change (YoY) +1.24%
Shares Change (QoQ) +0.33%
Owned by Insiders (%) 25.96%
Owned by Institutions (%) 60.47%
Float 17.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.86
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.18.

Current Ratio 2.58
Quick Ratio 2.48
Debt / Equity 0.18
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -160.10% and return on invested capital (ROIC) is -283.69%.

Return on Equity (ROE) -160.10%
Return on Assets (ROA) -116.10%
Return on Capital (ROIC) -283.69%
Revenue Per Employee n/a
Profits Per Employee -$1.19M
Employee Count 41
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -1.91% in the last 52 weeks. The beta is 0.04, so Vincerx Pharma's price volatility has been lower than the market average.

Beta (1Y) 0.04
52-Week Price Change -1.91%
50-Day Moving Average 0.91
200-Day Moving Average 1.12
Relative Strength Index (RSI) 34.62
Average Volume (30 Days) 50,847

Short Selling Information

The latest short interest is 128,670, so 0.60% of the outstanding shares have been sold short.

Short Interest 128,670
Short Previous Month 130,378
Short % of Shares Out 0.60%
Short % of Float 0.73%
Short Ratio (days to cover) 3.23

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -52.50M
Pretax Income -48.85M
Net Income -48.85M
EBITDA -47.95M
EBIT -48.85M
Earnings Per Share (EPS) -$2.31
Full Income Statement

Balance Sheet

The company has $20.87 million in cash and $2.77 million in debt, giving a net cash position of $18.11 million or $0.85 per share.

Cash & Cash Equivalents 20.87M
Total Debt 2.77M
Net Cash 18.11M
Net Cash Per Share $0.85
Equity / Book Value 15.74M
Book Value Per Share 0.74
Working Capital 13.97M
Full Balance Sheet

Cash Flow

Operating Cash Flow -46.25M
Capital Expenditures n/a
Free Cash Flow -46.25M
FCF Per Share -$2.17
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Vincerx Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -360.32%
FCF Yield -341.15%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -1.24%
Shareholder Yield -1.24%

Analyst Forecast

The average price target for Vincerx Pharma is $4.00, which is 524.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.00
Price Target Difference 524.81%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -32.73%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2